Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC) - Uppaluri, R; Zolkind, P; Lin, T
J Clin Oncol 2017; 35 (suppl.): abstr 6012